drugdeliverybusiness4d
Class action suit targets Abbott FreeStyle Libre amid claims of data sharing
Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...
FDA hits Abbott FreeStyle Libre 3 recall with Class I tag
The US Food and Drug Administration (FDA) has tagged Abbott’s recent recall of its faulty FreeStyle Libre 3 sensors as Class ...
WGN-TV17d
Abbott's Lingo™ Continuous Glucose Monitor for Health and Wellness Now Available in the U.S.
Lingo is based on Abbott's world-leading FreeStyle Libre® continuous glucose monitoring technology 1, now used by more than 6 million people with diabetes globally 1. "There is a great deal of ...
medtechdive2d
Abbott ramps up Libre 3 production amid shortages
Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.
Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy?
Let's not forget about Abbott Laboratories' impressive streak of 52 consecutive annual dividend increases, which also makes ...
pharmaphorum24d
Real-time Abbott glucose monitor available to NHS after UK launch
The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device ...